We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
+4.86%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$667B
AUM Growth
-$78.5B
Cap. Flow
-$15B
Cap. Flow %
-2.25%
Top 10 Hldgs %
32.39%
Holding
14,586
New
1,953
Increased
4,555
Reduced
6,197
Closed
1,571

Top Buys

Rank Stock Value
1
C icon
Citigroup
C
+$1.13B
2
T icon
AT&T
T
+$275M
3
AAPL icon
Apple
AAPL
+$248M
4
DIS icon
Walt Disney
DIS
+$235M
5
NKE icon
Nike
NKE
+$195M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.82%
2 Technology 1.6%
3 Consumer Discretionary 1.3%
4 Financials 0.99%
5 Communication Services 0.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTNP
12601
DELISTED
Titan Pharmaceuticals
TTNP
$40K ﹤0.01%
+1,947
New +$58.7K
CGRN
12602
DELISTED
Capstone Green Energy Corporation Common Stock
CGRN
$40K ﹤0.01%
+11,968
New +$59.1K
ADVM
12603
DELISTED
Adverum Biotechnologies
ADVM
$39K ﹤0.01%
2,231
+759
+52% +$15.2K
BGMS
12604
CALL
Bio Green Med Solution Inc
BGMS
$5.9M
$39K ﹤0.01%
3
-4
-57% -$64.2K
LVO icon
12605
CALL
LiveOne
LVO
$54.8M
$39K ﹤0.01%
3,030
-14,100
-82% -$309K
SMMT icon
12606
Summit Therapeutics
SMMT
$11.4B
$39K ﹤0.01%
14,461
+1,641
+13% +$7.89K
TLSA icon
12607
Tiziana Life Sciences
TLSA
$135M
$39K ﹤0.01%
41,028
+17,839
+77% +$23.6K
NTBL
12608
PUT
DELISTED
Notable Labs, Ltd. Ordinary Shares
NTBL
$39K ﹤0.01%
571
-100
-15% -$7.71K
BURU.WS
12609
DELISTED
Nuburu, Inc. Redeemable Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
BURU.WS
$39K ﹤0.01%
75,000
QFTA.WS
12610
DELISTED
Quantum FinTech Acquisition Corporation Warrants, each warrant exercisable for one-half of one share of Common Stock at an exercise price of $11.50
QFTA.WS
$39K ﹤0.01%
+77,165
New +$37.4K
MUDSW
12611
DELISTED
Mudrick Capital Acquisition Corporation II Warrant
MUDSW
$39K ﹤0.01%
50,000
AXU
12612
CALL
DELISTED
Alexco Resource Corp
AXU
$39K ﹤0.01%
22,200
AUTO
12613
CALL
DELISTED
AutoWeb, Inc. Common Stock
AUTO
$39K ﹤0.01%
11,400
-700
-6% -$2.17K
CALA
12614
CALL
DELISTED
Calithera Biosciences, Inc
CALA
$39K ﹤0.01%
2,930
-8,050
-73% -$202K
COCHW icon
12615
Envoy Medical Warrant
COCHW
$441K
$38K ﹤0.01%
+48,853
New +$35.8K
GYRE icon
12616
Gyre Therapeutics
GYRE
$705M
$38K ﹤0.01%
+5,457
New +$93.3K
UGP icon
12617
Ultrapar
UGP
$6.86B
$38K ﹤0.01%
14,513
-14,499
-50% -$36.9K
TRAW icon
12618
PUT
Traws Pharma
TRAW
$9.17M
$38K ﹤0.01%
596
-1,964
-77% -$158K
ATRS
12619
CALL
DELISTED
Antares Pharma, Inc.
ATRS
$38K ﹤0.01%
+10,700
New +$37.4K
CAAS icon
12620
PUT
China Automotive Systems
CAAS
$159M
$37K ﹤0.01%
13,800
+1,000
+8% +$3.26K
CEPU
12621
Central Puerto
CEPU
$2.04B
$37K ﹤0.01%
11,802
+1,375
+13% +$4.73K
FURY
12622
Fury Gold Mines
FURY
$120M
$37K ﹤0.01%
+58,504
New +$38.9K
IMRN
12623
Immuron
IMRN
$9.44M
$37K ﹤0.01%
+14,615
New +$49.2K
KRMD icon
12624
KORU Medical Systems
KRMD
$148M
$37K ﹤0.01%
12,236
-3,015
-20% -$9.24K
LGHL
12625
Lion Group Holding
LGHL
$501K
0

Similar funds

Jeff Yass's Q4 2021 Portfolio in Review

As of Q4 2021, Jeff Yass held 14,586 positions worth $667B, down 11% from $745B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q4 2021 filing shows 1,953 new, 4,555 increased, 6,197 reduced and 1,571 closed positions. Its largest new stake was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.4B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 93% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q4 2021 buy was iShares Core MSCI Emerging Markets ETF: 1,306,619 shares worth $78.2M.
  • Jeff Yass added most to Citigroup in Q4 2021, an estimated $1.13B increase.
  • Jeff Yass's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.4B.
  • Jeff Yass fully exited Stamps.com, Inc. in Q4 2021, selling an estimated $78.8M.
  • Jeff Yass's ten largest holdings make up 32% of its $667B portfolio in Q4 2021.
  • Jeff Yass opened 1,953 new positions and closed 1,571 in Q4 2021.
  • Jeff Yass's portfolio value fell 11% quarter-over-quarter to $667B.

Based on Susquehanna International Group's 13F filing for Q4 2021, filed 14 Feb 2022.